Perspectives Archives - Page 3 of 5

Three Pillars for Setting up Biotech Startups for Success

No biotech startup can walk the path to success all alone and unprepared, especially not without the three pillars of Data, Strategy and Team, as…

Martyna Wroblewska21.09.2022

Perspectives

Value-based pricing in pharmaceuticals – hype or hope?

In the face of stagnant healthcare budgets, and evergrowing demand for care, value-based pricing has real potential to bring value to pharma companies, payers, patients…

Arianna30.06.2022

Perspectives

Switzerland is #1 in biotech globally according to a nature biotech study

In a true tour de force effort to map out a global biotech ranking the nature biotech article “The Worldview national ranking of health biotech…

Arianna30.06.2022

Perspectives

14 legal questions every biotech startup should ask

Walder Wyss is one of the most successful and fastest-growing Swiss law ﬁrms. Since March 2021, they’re also one of our domain partners. Dr. iur.,…

Arianna17.06.2022

Perspectives

File or fail in the age of publish or perish

When is the right time to file a patent? The decision of when to file a patent application depends on a combination of business and…

Arianna28.02.2022

Perspectives

Your first European launch: a prescription for growth

For non-European biopharmaceutical companies, launching a drug in the EU can be extremely challenging. but, with the right drug and a clear strategy, it can…

Arianna28.02.2022

Perspectives

Business development deals in biotech: preparation is everything

What happens after a biotech has found their dream biopharma company to collaborate with? To make a deal, they should be prepared to talk, ask,…

Arianna04.02.2022

Perspectives

Featured Interview: Stephan Emmerth, Director Business Development & Operations, BaseLaunch

Swiss biotech venture accelerator and incubator BaseLaunch was started in 2017 to help launch and grow the next generation of biotech companies. The accelerator has…

clement16.12.2021

Perspectives

“We master all the tricks of the trade” Interview with Thomas Fessard CEO of SpiroChem

Founded in 2011, the company moved to Basel in 2017. Today, SpiroChem has gained an excellent reputation for delivering best-in-class chemistry services and works with…

clement01.11.2021

Perspectives

Building a biotechnology ecosystem

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. The company provides affordable and non-exclusive access to…

clement01.11.2021

Perspectives

Three Pillars for Setting up Biotech Startups for Success

Value-based pricing in pharmaceuticals – hype or hope?

Switzerland is #1 in biotech globally according to a nature biotech study

14 legal questions every biotech startup should ask

File or fail in the age of publish or perish

Your first European launch: a prescription for growth

Business development deals in biotech: preparation is everything

Featured Interview: Stephan Emmerth, Director Business Development & Operations, BaseLaunch

“We master all the tricks of the trade” Interview with Thomas Fessard CEO of SpiroChem

Building a biotechnology ecosystem

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us